A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

Last updated: March 6, 2026
Sponsor: Mayo Clinic
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Survey Administration

Audio Recording

Best Practice

Clinical Study ID

NCT06122064
23-003089
NCI-2023-07463
23-003089
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This clinical trial compares the use of a shared decision-making communication tool during a clinical encounter to standard care for improving the quality of the shared decision-making process among patients with non-small cell lung cancer. Lung cancer patients are faced with many decisions about their treatment options. Studies have found that patients are most satisfied if they perceive an effort by their physician to share decision making and are afforded sufficient time to make their decision. Shared decision-making tools can help physicians guide the conversation, offer tailored estimates of the potential benefits, harms, and practical inconveniences of the available options, and support deliberations that take into account patient biological and biographical circumstances, goals, and priorities. Incorporating a shared decision-making communication tool into standard clinical encounters may improve the shared-decision making process as well as patient satisfaction with their treatment choice.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • CLINICIANS:

  • All clinicians within identified departments participating are eligible (doctor ofmedicine [MD]/doctor of osteopathy [DO], fellows/residents, physician assistant [PA]/nurse practitioner [NP])

  • PATIENTS:

  • Adult patients (>= 18 years of age)

  • Appointments at Mayo Clinic in Rochester

  • Non-small cell lung cancer (NSCLC) stage > 1B

  • Eligible by their oncologist for adjuvant treatment

Exclusion

Exclusion Criteria:

  • Exclude patient with major barriers to provide written informed consent or toparticipate in shared decision-making (i.e., dementia, severe hearing or visualimpairment)

Study Design

Total Participants: 100
Treatment Group(s): 6
Primary Treatment: Survey Administration
Phase:
Study Start date:
November 20, 2023
Estimated Completion Date:
October 31, 2026

Study Description

PRIMARY OBJECTIVES:

I. Encounters where standard of care and the non-small cell lung cancer (NSCLC) choice conversation aid were utilized will have an improvement in the quality of the shared decision-making process over encounters with standard of care alone.

II. Patients with encounters where the NSCLC choice conversation aid was used along with standard of care will have decreased decisional conflict in regard to treatment choice compared to standard of care alone.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients attend a standard of care visit with their clinician on study.

ARM II: Patients attend a standard of care visit with the use of the shared decision-making conversation tool by the clinician on study.

After completion of study intervention, patients are followed up at 2 and 6 weeks.

Connect with a study center

  • Mayo Clinic in Rochester

    Rochester, Minnesota 55905
    United States

    Active - Recruiting

  • Mayo Clinic in Rochester

    Rochester 5043473, Minnesota 5037779 55905
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.